1-12 of 12
Agnès Guerci-Bresler, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 3 Study of Lenalidomide (LEN) Vs Placebo in Non-Transfusion Dependent (TD) Low Risk Del(5q) MDS Patients - Interim Analysis of the European Sintra-REV Trial

Félix López Cadenas, MD, Eva Lumbreras, Blanca Xicoy, MD, Joaquín Sánchez, MD, Rosa Coll, MD, Bohrane Slama, MD, Jose Angel Hernandez-Rivas, MD PhD, Sylvain Thepot, MD, Teresa Bernal, MD PhD, Beatriz Arrizabalaga, MD PhD, Agnès Guerci-Bresler, MD PhD, Guillermo F Sanz, MD PhD, Joan Bargay, MD, Maria Luz Amigo, MD, Raquel de Paz, MD, Benet Nomdedeu, MD, Aristoteles Giagounidis, Uwe Platzbecker, Stefan Wickenhauser, Katharina S. Götze, Ali Arar, Jesus María Hernández Rivas, MD PhD, Pierre Fenaux, MD PhD, Consuelo Del Cañizo, MDPhD, Maria Diez-Campelo, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-140339
Published: 2020
Journal Articles

Prospective Evaluation of ABL Kinase Domain Mutational Analysis By Next-Generation-Sequencing in Newly Diagnosed CP CML Patients Undergoing First-Line Treatment with Nilotinib Alone or Nilotinib + Pegylated Interferon-α2a in a Prospective Phase III Trial

Hugues de Lavallade, MD PhD, Sophie Jackson, BSc, Aytug Kizilors, PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnes Guerci-Bresler, MD PhD, Delphine Rea, MD, Claudine Chollet, MSc, Stephane Morisset, BioStat, Fanny Robbesyn, BSc, Francois-Xavier Mahon, MD PhD, Stephanie Dulucq, PharmD, PhD, Franck E Nicolini, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 664.
https://doi.org/10.1182/blood-2019-125108
Published: 2019
Journal Articles

The Combination of Nilotinib + Pegylated IFN Alpha 2a Provides Somewhat Higher Cumulative Incidence Rates of MR4.5 at M36 Versus Nilotinib Alone in Newly Diagnosed CP CML Patients. Updated Results of the Petals Phase III National Study.

Franck E Nicolini, MD PhD, Gabriel Etienne, MD PhD, Francoise Huguet, MD, Agnès Guerci-Bresler, MD PhD, Aude Charbonnier, MD PhD, Martine Escoffre-Barbe, MD, Viviane Dubruille, MD, Hyacinthe Johnson-Ansah, MD, Laurence Legros, MD PhD, Valerie Coiteux, MD, Pascale Cony-Makhoul, MD, Pascal Lenain, MD, Lydia Roy, MD, Philippe Rousselot, MD PhD, Denis Guyotat, MD PhD, Jean-Christophe Ianotto, MD PhD, Martine Gardembas, MD, Eric Deconinck, MD PhD, Fabrice Larosa, MD, Denis Caillot, MD, Pascal Turlure, MD, Stephane Courby, MD, Philippe Quittet, MD, Eric Hermet, MD, Shanti Ame, MD, Simona Lapusan, MD, Alexandre Deloire, CRA, Stephane Morisset, BioStat, Madeleine Etienne, CRA, Delphine Rea, MD, Stephanie Dulucq, PharmD, PhD, Francois-Xavier Mahon, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 494.
https://doi.org/10.1182/blood-2019-123674
Published: 2019
Journal Articles

Using Healthcare Claims Data to Analyze the Prevalence of Chronic Myeloid Leukemia in France: A Nationwide Population-Based Study

Stephanie Foulon, MD, Pascale Cony-Makhoul, MD PhD, Agnes Guerci-Bresler, MD PhD, Marc Delord, PhD, Eric Solary, MD PhD, Alain Monnereau, MD PhD, Julia Bonastre, PhD, Pascale Tubert Bitter, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3015.
https://doi.org/10.1182/blood-2018-99-111489
Published: 2018
Journal Articles

Second TKI Discontinuation in CML Patients That Failed First Discontinuation and Subsequently Regained Deep Molecular Response after TKI Re-Challenge

Thomas Pagliardini, Franck E. Nicolini, MD PhD, Stephane Giraudier, MD PhD, Philippe Rousselot, Gabriel Etienne, MD PhD, Françoise Huguet, MD, Agnes Guerci-Bresler, MD PhD, Bruno R. Varet, MDPhD, Martine Escoffre, MD, Stephane Morisset, Stat, Francois-Xavier Mahon, Laurence Legros, MD PhD
Journal: Blood
Blood (2016) 128 (22): 788.
https://doi.org/10.1182/blood.V128.22.788.788
Published: 2016
Journal Articles

Characteristics and Outcomes of Unselected Adolescents and Young Adults Patients with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

Stéphanie Bernardin, Franck E. Nicolini, MD PhD, Delphine Rea, MD PhD, Mael Haiblig, MD, Martine Gardembas, MD, Gabriel Etienne, MD PhD, P Cony-Makhoul, MD, Martine Escoffre-Barbe, MD, Stephane Giraudier, Agnes Guerci-Bresler, MD PhD, Valérie Coiteux, MD, Marc G Berger, MD PhD Professor, Lydia Roy, MD, Anne Corby, MD, Pierre-Simon Rohrlich, MDPhD, Françoise Huguet, MD, Laurence Legros, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1803.
https://doi.org/10.1182/blood.V124.21.1803.1803
Published: 2014
Journal Articles

Prospective Analysis of the Quality of Life of Chronic Phase CML Patients on Second Generation Tyrosine Kinase Inhibitors after Imatinib Failure. an Observational Study

Franck E. Nicolini, MD PhD, Nicolas Vantard, Pharm.D, Stephane Giraudier, MD PhD, Mael Heiblig, MD, Hyacinthe Johnson-Ansah, MD, Lydia Roy, MD, Claude-Eric Bulabois, MD, Denis Caillot, MD, Martine Escoffre-Barbe, MD, Eric Jourdan, MD PhD, Pascale Cony-Makhoul, MD, Agnes Guerci-Bresler, MD PhD, Laurence Legros, MD PhD, Laurent Sutton, MD, Martine Gardembas, MD, Emmanuel Gyan, MD PhD, Annelore Le Maux, Stat., Carine Guinard-Azadian, MD, Hesham Mohamed, MD, Mohamad Sobh, Pharm.M., Helene Labussiere-Wallet, MD, Gabriel Etienne, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1321.
https://doi.org/10.1182/blood.V124.21.1321.1321
Published: 2014
Journal Articles

A Phase II Study Of The Efficacy and Safety Of An Intensified Schedule Of Azacitidine (AZA) In Intermediate-2 and High Risk MDS Patients

Lionel Ades, Agnès Guerci-Bresler, MD, PhD, Pascale Cony Makhoul, Laurence Legros, MD, PhD, Jacques Delaunay, MD, Christian Recher, MD PhD, Kristell Desseaux, Benedicte Samey, Sylvie Chevret, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1513.
https://doi.org/10.1182/blood.V122.21.1513.1513
Published: 2013
Journal Articles

Outcomes In RBC Transfusion-Dependent Patients (Pts) With Low-/Intermediate (Int)-1-Risk Myelodysplastic Syndromes (MDS) With Isolated Deletion 5q Treated With Lenalidomide (LEN): A Subset Analysis From The MDS-004 Study

Aristoteles Giagounidis, MD, PhD, Ghulam J. Mufti, MD, PhD, Moshe Mittelman, MD, Guillermo Sanz, MD, PhD, Uwe Platzbecker, MD, PhD, Petra Muus, MD, PhD, Dominik Selleslag, MD, Odile Beyne-Rauzy, MD, PhD, Peter te Boekhorst, MD, PhD, Consuelo del Cañizo, MD, PhD, Agnès Guerci-Bresler, MD, PhD, Michael Lübbert, MD, PhD, Bruno Quesnel, MD, PhD, Arnold Ganser, MD, David Bowen, MD, PhD, Brigitte Schlegelberger, MD, PhD, Tommy Fu, Bouchra Benettaib, MD, Eva Hellström-Lindberg, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2753.
https://doi.org/10.1182/blood.V122.21.2753.2753
Published: 2013
Journal Articles

Validation Of The Revised International Prognostic Scoring System (IPSS-R) In 1000 Newly Diagnosed MDS Patients With Low- and Intermediate-1 Risk MDS In The European Leukemianet MDS (EUMDS) Registry

Louise de Swart, Alex Smith, Tom Johnston, Detlef Haase, MD, Jackie Droste, Pierre Fenaux, Argiris Symeonidis, MD, PhD, Guillermo Sanz, MD, PhD, Eva Hellström-Lindberg, Jaroslav Cermak, Ass. Prof., PhD, Ulrich Germing, MD, Reinhard Stauder, MD, MSc, Otilia Georgescu, Marius MacKenzie, Luca Malcovati, MD, Mette Skov Holm, Antonio Medina Almeida, Krzysztof Madry, Borhane Slama, Agnès Guerci-Bresler, MD, PhD, Laurence Sanhes, MD, Odile Beyne-Rauzy, Elisa Luño, MD, David Bowen, MD, PhD, Theo de Witte
Journal: Blood
Blood (2013) 122 (21): 2770.
https://doi.org/10.1182/blood.V122.21.2770.2770
Published: 2013
Journal Articles

Prognostic Factors Of Response and Survival To Azacitidine (AZA) +/- EPO In RBC Transfusion Dependent (TD) IPSS Low and Int-1 (LR) MDS Resistant To EPO, With Particular Emphasis Of Genetic Lesions: A Study By The GFM

Sylvain Thepot, Raouf Ben Abdelali, MD, Sylvie Chevret, Aline Renneville, Odile Beyne Rauzy, MD PHD, Thomas Prebet, MD, PhD, Sophie Park, Aspasia Stamatoullas, MD, Agnès Guerci-Bresler, MD, PhD, Stéphane Cheze, Gerard Tertian, Bachra Choufi, MD, Laurence Legros, MD, PhD, Jean-Noel Bastie, MD, PhD, Jacques Delaunay, MD, Eric Wattel, Francois Dreyfus, MD, Norbert Vey, MD, Claude Preudhomme, Pierre Fenaux, MD, PhD, Claude Gardin
Journal: Blood
Blood (2013) 122 (21): 658.
https://doi.org/10.1182/blood.V122.21.658.658
Published: 2013
Journal Articles

Arsenic Trioxide (ATO) Or ATRA For Consolidation Treatment Of Standard Risk Non Elderly Newly Diagnosed APL– Second Interim Analysis Of a Randomized Trial (APL 2006) By The French Belgian Swiss APL Group

Lionel Ades, Sylvie Chevret, Emmanuel Raffoux, Arnaud Pigneux, MD, PhD, Xavier Thomas, MD, PhD, Dominique Bordessoule, MD, PhD, Norbert Vey, MD PhD, Agnès Guerci-Bresler, MD, PhD, Thierry Lamy, MD, PhD, Christian Recher, MD PhD, Jean-Francois Lambert, Olivier Tournilhac, MD, PhD, Cécile Pautas, Martin Carre, MD, PhD, Dominique Bron, MD, PhD, Jacques Delaunay, MD, Eric Deconinck, MD, PhD, Bruno Quesnel, MD, PhD, Stéphane de Botton, Aspasia Stamatoullas, MD, Norbert Ifrah, MD, Christine Chomienne, MD, PhD, Herve Dombret, MD, PhD, Laurent Degos, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 495.
https://doi.org/10.1182/blood.V122.21.495.495
Published: 2013